(Q53376889)

13 May 2018

title

The inflammatory milieu in idiopathic inflammatory myositis. (English)

1 reference

13 May 2018

0 references

Ann M Reed

1

1 reference

13 May 2018

Floranne Ernste

series ordinal

2

1 reference

13 May 2018

publication date

1 August 2009

1 reference

13 May 2018

Current Rheumatology Reports

published in

1 reference

13 May 2018

volume

11

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

295-301

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s11926-009-0041-1

exact match

0 references

cites work

Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression

1 reference

https://api.crossref.org/works/10.1007%2FS11926-009-0041-1

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-009-0041-1

A local antigen-driven humoral response is present in the inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-009-0041-1

Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-009-0041-1

Differential expression of chemokines in inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-009-0041-1

Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis.

21 January 2018

1 reference

12 December 2020

Vascular Deposits of Immunoglobulin and Complement in Idiopathic Inflammatory Myopathy

1 reference

12 December 2020

Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells.

1 reference

12 December 2020

MHC Class I overexpression on muscles in early juvenile dermatomyositis

1 reference

12 December 2020

Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.

1 reference

12 December 2020

Gene expression profiling in human autoimmunity.

1 reference

12 December 2020

Myeloid dendritic cells in inclusion-body myositis and polymyositis.

1 reference

12 December 2020

Polymyositis and dermatomyositis

1 reference

12 December 2020

Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis

1 reference

12 December 2020

Expression of tumor necrosis factor-alpha in muscles of polymyositis

1 reference

12 December 2020

Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies.

1 reference

12 December 2020

Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis

1 reference

12 December 2020

Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis

1 reference

12 December 2020

Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies

1 reference

12 December 2020

Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies

1 reference

12 December 2020

Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors

1 reference

12 December 2020

Beta-chemokine receptor expression in idiopathic inflammatory myopathies.

1 reference

12 December 2020

The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy

1 reference

12 December 2020

Plasma cells in muscle in inclusion body myositis and polymyositis.

1 reference

12 December 2020

Cell death and oxidative damage in inflammatory myopathies.

1 reference

12 December 2020

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

1 reference

12 December 2020

Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.

1 reference

12 December 2020

Cellular mechanisms in inflammatory myopathies.

1 reference

12 December 2020

Type I interferons (alpha/beta) in immunity and autoimmunity

1 reference

12 December 2020

Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis

1 reference

12 December 2020

Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis

1 reference

12 December 2020

Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies

1 reference

12 December 2020

Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes

1 reference

12 December 2020

Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis

1 reference

12 December 2020

Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies.

1 reference

12 December 2020

The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis.

1 reference

12 December 2020

TH17 cells in development: an updated view of their molecular identity and genetic programming

1 reference

12 December 2020

Distinct inflammatory properties of late-activated macrophages in inflammatory myopathies.

1 reference

12 December 2020

Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells

1 reference

12 December 2020

Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases

1 reference

12 December 2020

Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

1 reference

12 December 2020

Expression of TNFalpha by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNFalpha-308A allele

1 reference

12 December 2020

Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies

1 reference

12 December 2020

Plasmacytoid dendritic cells in immunity

1 reference

12 December 2020

Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids

1 reference

12 December 2020

Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis

1 reference

12 December 2020

TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications

1 reference

12 December 2020

Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.

1 reference

12 December 2020

Monocyte/macrophage differentiation in dermatomyositis and polymyositis

1 reference

12 December 2020

Induction and effector functions of T(H)17 cells.

1 reference

12 December 2020

Pathogenesis of myositis in children

1 reference

12 December 2020

Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.

1 reference

12 December 2020

Expression of granulysin in polymyositis and inclusion-body myositis

1 reference

12 December 2020

Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction

1 reference

12 December 2020

Role of major histocompatibility complex class I molecules in autoimmune myositis

1 reference

12 December 2020

MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement

1 reference

12 December 2020

Increased IL-15 production of muscle cells in polymyositis and dermatomyositis

1 reference

12 December 2020

Cytokine expression profile in idiopathic inflammatory myopathies

1 reference

12 December 2020

Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies

1 reference

12 December 2020

Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells

1 reference

12 December 2020

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis

1 reference

12 December 2020

A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies

1 reference

12 December 2020

Th17 cells in human disease.

1 reference

12 December 2020

Local expression of cytokines in idiopathic inflammatory myopathies

1 reference

12 December 2020

Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies.

1 reference

12 December 2020

10.1007/S11926-009-0041-1

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

19691933

1 reference

13 May 2018